Ohio Governor Mike DeWine and Lt. Governor Jon Husted on Monday announced the Cleveland Innovation District, a transformational collaboration of Northeast Ohio's leading healthcare and higher education institutions.

The Cleveland Innovation District brings together Case Western Reserve University, Cleveland Clinic, University Hospitals, The MetroHealth System and Cleveland State University in partnership with the Ohio Development Services Agency and JobsOhio to drive advancements in healthcare education, research and development. The initiative's goal is to bring 20,000 new jobs to the area over 10 years, an expected economic impact of $3 billion for Cleveland and Ohio that also generates $3 billion in research activity.

In a message to the Case Western Reserve University Community this week, Interim President Scott Cowen noted, "If we succeed, Northeast Ohio will take its place among the nation’s preeminent hubs for health care and biomedical research." Additional details about the agreement will be shared with the university community as they become available. "We will concentrate on advancing our expertise in areas that include but are not limited to artificial intelligence, big data, and drug development, with a particular emphasis on their implications for cancer, infectious diseases, neurological disorders and cardiac issues," said Cowen.

Researchers at Cleveland Clinic's Ob/Gyn & Women's Health Institute and Lerner Research Institute recently published a retrospective study in Gynecologic Oncology which found that women with newly diagnosed stage III or IV epithelial ovarian cancer and received antibiotics following cytoreductive surgery and platinum chemotherapy had worse outcomes in comparison to those who did not receive antibiotics.

Cleveland Clinic's Peter G. Rose, MD, Ofer Reizes, PhD and Roberto Vargas, MD are co-authors on the. study and members of the Case Comprehensive Cancer Center.

Recent security measures across the Cleveland Clinic network made the Case CCC Marketing and Communications Request Form inaccessible to members of our community.

A new submission form is now available for use. There is a lot of important work and exciting accomplishments occurring throughout and related to the Case Comprehensive Cancer Center - and we want to know all about it! As a large center that spans three institutions, our team is making an effort to streamline distribution and project requests in order to best serve our membership and community.

As a reminder, this form may be used to submit any of the following requests:

Let our team know what you think about the form - we're happy to help out and hear your suggestions! Reach out to Case CCC marketing and communications anytime at cancer@case.edu.

A postdoctoral position is available at the School of Medicine of Case Western Reserve University and the Case Comprehensive Cancer Center to study the molecular mechanisms by which specific oncogene products drive tumorigenesis and invasiveness in colorectal cancer. The primary goal of the project is to develop novel, target-specific inhibitors for studies in cell and animal models of the disease.

The postdoc will work independently on research projects under the supervision of the principal investigator. The candidate must have a strong foundation and experience in all aspects of cell signaling and cancer cell biology. The candidate will be expected to contribute to the preparation of manuscripts and reports, and to regularly present their findings at various internal and external meetings. Candidates must have an MD and/or PhD with relevant experience, a strong record of productivity with evidence of first-author publications, and excellent communication skills. This is an outstanding opportunity for highly motivated individuals with strong bench and organizational skills. Competitive salary commensurate with experience, and benefits; NIH funded.

Interested applicants should submit a CV, a letter of interest and contact information of three individuals that can provide academic references upon request to:

Dr. D. Manor

School of Medicine, WG-48

Case Western Reserve University

Cleveland, OH 44106

The Center for Reducing Health Disparities, established jointly by the MetroHealth System and Case Western Reserve University, seeks innovative pilot projects that partner with community organizations to better understand and/or reduce health disparities. Investigators from underrepresented groups are highly encouraged to apply.

Stand Up To Cancer (SU2C) invites applications for participation in an Ideas Lab to establish the SU2C Head and Neck Cancer Research Team. The Research Team will bring new approaches to treating head and neck squamous cell carcinoma (HNSCC) cancer into the clinical setting, with a focus on HPV-related and Fanconi anemia (FA)-related cancers. The funding available for the program is up to $3,250,000 over the 3-year grant program.